JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HEYMANN, H.
Right arrow Articles by FIESER, L. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by HEYMANN, H.
Right arrow Articles by FIESER, L. F.
Journal of Pharmacology And Experimental Therapeutics, Vol. 94, Issue 2, 97-111, 1948
Copyright © 1948 by American Society for Pharmacology and Experimental Therapeutics


NAPHTHOQUINONE ANTIMALARIALS

XIX. Antirespiratory Study of Protein Binding

HANS HEYMANN 1 and LOUIS F. FIESER 1

1 Chemical Laboratory, Harvard University

1. Satisfactory methods have been found for the accurate assay of naphthoquinone pigment in plasma samples and for the preparation of plasma extracts (alcohol) suitable for respiratory study.

2. Difficulties encountered in ether extraction are attributable to the binding of naphthoquinone to protein. Exploratory dialysis and solubility experiments show that the compounds are bound particularly to albumin; a typical naphthoquinone-albumin complex has an apparent acidity about 1.6 pK units lower than that of the free naphthoquinone. The drug-binding power of three plasmas, as judged by dialysis experiments, is in the order: human monkey duck.

3. Little if any naphthoquinone diffuses from the plasma into the red blood cells.

4. Protein antagonism to drug action as measured by the depression of the inhibitory action of naphthoquinones on the respiration of parasitized erythrocytes, decreases in the order: human serum chicken serum duck serum; the difference in protein antagonism between chicken and duck plasma may account for marked differences noted in the antimalarial potency of naphthoquinones in these species.

5. Susceptibility to human-protein antagonism varies markedly from compound to compound, and the characterization of naphthoquinones with respect to this factor affords a further criterion for the laboratory evaluation of their promise in therapy.

Submitted on June 7, 1948







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1948 by the American Society for Pharmacology and Experimental Therapeutics.